REX Peptide ETF PEPT
Morningstar’s Analysis PEPT
There is no Morningstar’s Analysis data available.
- Current Portfolio Date
- Equity Holdings—
- Bond Holdings—
- Other Holdings—
- % Assets in Top 10 Holdings71.7
Top 10 Holdings | % Portfolio Weight | Market Value USD | Sector |
|---|---|---|---|
Eli Lilly and Co | 13.74 | 450,976 | Healthcare |
Ascendis Pharma AS | 11.31 | 371,183 | Healthcare |
Novo Nordisk AS ADR | 10.29 | 337,626 | Healthcare |
Insulet Corp | 7.78 | 255,420 | Healthcare |
Sanofi SA | 5.97 | 195,867 | Healthcare |
Protagonist Therapeutics Inc | 5.93 | 194,735 | Healthcare |
Rhythm Pharmaceuticals Inc | 5.52 | 181,211 | Healthcare |
Darling Ingredients Inc | 4.01 | 131,438 | Consumer Defensive |
Viking Therapeutics Inc | 3.65 | 119,876 | Healthcare |
Bachem Holding AG | 3.54 | 116,046 | Healthcare |